申请人:Kureha Chemical Industry Co., Ltd.
公开号:EP1121931A1
公开(公告)日:2001-08-08
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming polymer base, preferably hydroxypropylmethylcellulose. The preparation may be coated with an enteric polymer base such as hydroxypropylmethylcellulose acetate succinate to thereby enhance solubility in the intestines.
When orally administered, the preparation can continuously release esculetin. Thus, the administration frequency and dose can be reduced and a therapeutic effect on arthropathy can be established.
本发明涉及一种控释埃斯库雷丁口服制剂。本发明的控释鱼藤素口服制剂包括凝胶形成聚合物基质,最好是羟丙基甲基纤维素。该制剂可涂覆羟丙基甲基纤维素醋酸琥珀酸酯等肠道聚合物基质,从而提高在肠道中的溶解度。
口服给药时,制剂可持续释放埃斯库莱汀。因此,可以减少给药次数和剂量,并对关节病产生治疗效果。